Press Releases
September 17, 2020 – Proniras Corporation Announces National Institute on Drug Abuse (NIDA) Grant Award to Pursue Treatment for Opioid Withdrawal
April 27, 2018 – Accelerator Life Science Partners Launches Proniras Corporation to Support Development of Tezampanel in the Treatment of Seizure Disorders
In the News
April 27, 2018 – Proniras Corp. launches in Seattle, scores $89.5 million contract to develop new seizure drug (Geekwire.com)